Viatris is rated a Sell due to persistent risks, weak financials, and a likely profit-taking event post-Q2 2026 earnings. Read more on VTRS stock here.

Stacking an FDA advisory panel with peptide sellers to greenlight unproven substances is regulatory surrender, not public reform.

A hastily reassembled Pharmacy Compounding Advisory Committee (PCAC) held meetings on July 23 and 24, 2026 to consider whether seven ...

The FDA is considering allowing compounding pharmacies to make six peptides. Research on wellness peptides like BPC-157 and TB-500 is largely limited to animal studies, with little evidence that ...

Calculating student loan interest can be pretty straightforward, but how you calculate it will vary depending on whether ...

The decision was largely expected by investors, who have seen markets begin to churn amid ongoing concerns about higher oil prices and AI spending.

Attention parents, begin investing ₹1,900 per month in your child's public provident fund or PPF account from the year they are born to set them up for crorepati status. (Pexels / Representative Image ...

Colibri Resource Corporation (CRUCF) has entered into a definitive arm's-length purchase and sale agreement to divest its remaining 49% interest in the Pilar Gold & Silver Project in Sonora, Mexico, ...

Atlanta Braves hitters are an aggressive bunch. Most of Atlanta's lineup go up to the plate with a swing-first mentality. When things are going well, that mindset has its benefits. However, when the ...

Every day, Dr. Alexander Weber finds himself fielding another round of questions about peptides — and whether the trendy therapies can help his patients recover from sports injuries or surgery. He ...

Realty Income has been a terrific dividend stock over the years. The REIT has increased its monthly payment 135 times since its public market listing in 1994, including the past 115 consecutive ...